{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:03:10Z","timestamp":1794873790525,"version":"4.9.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>This article discusses publications assessing the prevalence, efficacy, and safety of opioid analgesics in patients with rheumatic diseases, including rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, ankylosing spondylitis, and systemic sclerosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Recent studies show long-term opioid use is common in patients with inflammatory rheumatic disease. We did not find any studies demonstrating improved function or pain control with long-term opioid use in people with rheumatic diseases. Some data shows potential adverse effects including increased risk for fractures and opioid poisoning hospitalizations. There is evidence demonstrating an association of opioid use with mental health disorders, fibromyalgia, obesity, and disability, although causative links have not been established. Only minimal reductions in opioid use were observed after initiation of biologic disease modifying antirheumatic drugs (DMARDs). Studies have shown delayed DMARD initiation and reduced DMARD use in patients on opioids, raising concerns that these analgesics may delay care or initially mask symptoms of active disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Available literature highlights high levels of opioid use in people with rheumatic disease, without scientific evidence to support efficacy for chronic pain control and increasing evidence of adverse events. These findings strongly suggest that opioids do not have a routine role in the chronic management of inflammatory rheumatic diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000000868","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T10:08:30Z","timestamp":1642586910000},"page":"95-102","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["Review of publications evaluating opioid use in patients with inflammatory rheumatic disease"],"prefix":"10.1097","volume":"34","author":[{"given":"Christine","family":"Anastasiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinoos","family":"Yazdany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain \u2013 United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/j.pain.0000000000001122","article-title":"Inflammation in the pathophysiology of neuropathic pain","volume":"159","author":"Sommer","year":"2018","journal-title":"Pain"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/0961203320919872","article-title":"Physiopathology of pain in systemic erythematosus lupus","volume":"29","author":"Nichilatti","year":"2020","journal-title":"Lupus"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/art.10515","article-title":"Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority","volume":"47","author":"Heiberg","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R6-20250526","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/pm\/pnab054","article-title":"Opioid prescribing among outpatients with rheumatoid arthritis","volume":"22","author":"Huang","year":"2021","journal-title":"Pain Med"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.semarthrit.2020.07.008","article-title":"Racial and ethnic differences in medication use among beneficiaries of social security disability insurance with rheumatoid arthritis","volume":"50","author":"Navarro-Mill\u00e1n","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/acr.24341","article-title":"Obesity and the risk of incident chronic opioid use in rheumatoid arthritis","volume":"73","author":"Baker","year":"2021","journal-title":"Arthritis Care Res"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s40744-021-00344-6","article-title":"Pain medication and corticosteroid use in ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis in the United States: a retrospective observational study","volume":"8","author":"Hunter","year":"2021","journal-title":"Rheumatol Ther"},{"key":"R10-20250526","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s40744-019-00175-6","article-title":"Changes in opioid utilization following tumor necrosis factor inhibitor initiation in patients with rheumatoid arthritis","volume":"6","author":"Park","year":"2019","journal-title":"Rheumatol Ther"},{"key":"R11-20250526","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/art.40152","article-title":"Changing trends in opioid use among patients with rheumatoid arthritis in the united states","volume":"69","author":"Curtis","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s12325-017-0596-6","article-title":"Changes in healthcare utilization after etanercept initiation in patients with rheumatoid arthritis: a retrospective claims analysis","volume":"34","author":"Accortt","year":"2017","journal-title":"Adv Ther"},{"key":"R13-20250526","first-page":"879","article-title":"Healthcare effect of disease-modifying antirheumatic drug use on patients with rheumatoid arthritis","volume":"25","author":"Boytsov","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/art.40789","article-title":"Chronic opioid use in rheumatoid arthritis: prevalence and predictors","volume":"71","author":"Lee","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/art.41240","article-title":"Physician prescribing patterns and risk of future long-term opioid use among patients with rheumatoid arthritis: a prospective observational cohort study","volume":"72","author":"Lee","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.2018.0899","article-title":"Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE randomized clinical trial","volume":"319","author":"Krebs","year":"2018","journal-title":"JAMA"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jama.2012.193412","article-title":"Opioid analgesics for rheumatoid arthritis pain","volume":"309","author":"Whittle","year":"2013","journal-title":"JAMA"},{"key":"R18-20250526","first-page":"CD003113","article-title":"Opioid therapy for treating rheumatoid arthritis pain","author":"Whittle","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/annrheumdis-2019-215328","article-title":"Medications associated with fracture risk in patients with rheumatoid arthritis","volume":"78","author":"Ozen","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S2213-8587(19)30254-2","article-title":"Opioid-induced endocrinopathies","volume":"8","author":"Fountas","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"e0220216","DOI":"10.1371\/journal.pone.0220216","article-title":"An updated analysis of opioids increasing the risk of fractures","volume":"15","author":"Yue","year":"2020","journal-title":"PLoS One"},{"issue":"(suppl 10)","key":"R22-20250526","article-title":"Opioid overdose hospitalizations in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"71","author":"Anastasiou","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11916-019-0803-z","article-title":"Off-label antidepressant use for treatment and management of chronic pain: evolving understanding and comprehensive review","volume":"23","author":"Urits","year":"2019","journal-title":"Curr Pain Headache Rep"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s10067-020-04955-2","article-title":"Mental health conditions and the risk of chronic opioid therapy among patients with rheumatoid arthritis: a retrospective veterans affairs cohort study","volume":"39","author":"Liberman","year":"2020","journal-title":"Clin Rheumatol"},{"key":"R26-20250526","doi-asserted-by":"crossref","first-page":"265","DOI":"10.15585\/mmwr.mm6610a1","article-title":"Characteristics of initial prescription episodes and likelihood of long-term opioid use - United States","volume":"66","author":"Shah","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.semarthrit.2018.07.003","article-title":"Delay in initiation of DMARD or anti-inflammatory therapy in patients newly diagnosed with rheumatoid arthritis: An analysis of United States Military Health System TRICARE beneficiaries","volume":"48","author":"Kimsey","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"R28-20250526","doi-asserted-by":"crossref","first-page":"819","DOI":"10.15585\/mmwr.mm6838a2","article-title":"Prescription opioid use in patients with and without systemic lupus erythematosus - Michigan Lupus Epidemiology and Surveillance Program","volume":"68","author":"Somers","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"e027495","DOI":"10.1136\/bmjopen-2018-027495","article-title":"Use of prescription opioids among patients with rheumatic diseases compared to patients with hypertension in the USA: a retrospective cohort study","volume":"9","author":"Chen","year":"2019","journal-title":"BMJ Open"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"e000435","DOI":"10.1136\/lupus-2020-000435","article-title":"Corticosteroid dosing and opioid use are high in patients with SLE and remain elevated after belimumab initiation: a retrospective claims database analysis","volume":"7","author":"Birt","year":"2020","journal-title":"Lupus Sci Med"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/acr.23777","article-title":"Persistently frequent emergency department utilization among persons with systemic lupus erythematosus","volume":"71","author":"Lee","year":"2019","journal-title":"Arthritis Care Res"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5055\/jom.2020.0547","article-title":"Opioid dispensation among systemic lupus erythematosus patients who persistently frequent the emergency department","volume":"16","author":"Lee","year":"2020","journal-title":"J Opioid Manag"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","article-title":"Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies","volume":"80","author":"Alinaghi","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R34-20250526","article-title":"Disease burden, symptoms, and use of analgesics in patients with psoriasis with or without psoriatic arthritis: a cross-sectional study","volume":"24","author":"Loft","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"R35-20250526","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/bjd.19865","article-title":"Trends in opioid prescribing at outpatient visits for psoriasis and psoriatic arthritis","volume":"185","author":"Taylor","year":"2021","journal-title":"Br J Dermatol"},{"key":"R36-20250526","first-page":"623","article-title":"Treatment patterns among patients with psoriatic arthritis treated with a biologic in the United States: descriptive analyses from an administrative claims database","volume":"24","author":"Walsh","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"key":"R37-20250526","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/archdermatol.2010.186","article-title":"The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study","volume":"146","author":"Olivier","year":"2010","journal-title":"Arch Dermatol"},{"key":"R38-20250526","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.jaad.2020.03.080","article-title":"Opioid prescribing in adults with and without psoriasis","volume":"83","author":"Noe","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R39-20250526","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00296-020-04544-1","article-title":"Longitudinal associations between depressive symptoms and clinical factors in ankylosing spondylitis patients: analysis from an observational cohort","volume":"40","author":"Hwang","year":"2020","journal-title":"Rheumatol Int"},{"key":"R40-20250526","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3899\/jrheum.170630","article-title":"Opioid analgesic use in patients with ankylosing spondylitis: an analysis of the prospective study of outcomes in an ankylosing spondylitis cohort","volume":"45","author":"Dau","year":"2018","journal-title":"J Rheumatol"},{"key":"R41-20250526","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3899\/jrheum.180972","article-title":"Opioid use in patients with ankylosing spondylitis is common in the united states: outcomes of a retrospective cohort study","volume":"46","author":"Sloan","year":"2019","journal-title":"J Rheumatol"},{"key":"R42-20250526","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1526-4637.2010.00849.x","article-title":"Oxycodone in the long-term treatment of chronic pain related to scleroderma skin ulcers","volume":"11","author":"Giuggioli","year":"2010","journal-title":"Pain Med"},{"key":"R43-20250526","first-page":"307","article-title":"Effectiveness and safety of oxycodone\/naloxone in the management of chronic pain in patients with systemic sclerosis with recurrent digital ulcers: two case reports","volume":"11","author":"Ughi","year":"2016","journal-title":"Clin Interv Aging"},{"issue":"(S1)","key":"R44-20250526","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1111\/pme.12914","article-title":"Opioid induced hyperalgesia","volume":"16","author":"Yi","year":"2015","journal-title":"Pain Med"},{"key":"R46-20250526","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-019-0137-5","article-title":"Opioid use disorder","volume":"6","author":"Strang","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"R47-20250526","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/annrheumdis-2017-212662","article-title":"EULAR recommendations for the health professional's approach to pain management in inflammatory arthritis and osteoarthritis","volume":"77","author":"Geenen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R48-20250526","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R50-20250526","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1097\/j.pain.0000000000000907","article-title":"Sustained improvements in pain, mood, function and opioid use post interdisciplinary pain rehabilitation in patients weaned from high and low dose chronic opioid therapy","volume":"158","author":"Huffman","year":"2017","journal-title":"Pain"},{"key":"R51-20250526","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/M17-0598","article-title":"Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review","volume":"167","author":"Frank","year":"2017","journal-title":"Ann Intern Med"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000868","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T17:17:22Z","timestamp":1748279842000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000868","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,18]]}}}